Diagnostic Solutions for Improved Health

Zora Biosciences is a diagnostics company. We identify markers of disease and develop them into robust high-throughput, value-added clinical methods.

CERT – Coronary Event Risk Test

CERT is a blood based diagnostic test that identifies patients who are at risk of heart attack or cardiovascular death. CERT helps to find high-risk patients even if their other clinical parameters such as LDL-C might suggest that they are not at an elevated risk. In Finland, CERT is known as Hertta.

Learn more about Hertta

15.3.2021

Zora Biosciences Licenses Ceramide Technology to Quest Diagnostics for Cardiovascular Mortality Prediction Test

Zora Biosciences Oy announced it has signed a license agreement with Quest Diagnostics, the world leader in diagnostic information services, for Zora's patented ceramide-analysis technology.

Zora publications

Please check our latest publications including our research on coronary event risk. The publications can be found from News - Publications.

Publications